Basel Medical Group Ltd Ordinary Shares (BMGL) — Capital Reinvestment Ratio
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($2.51 Million) in capital expenditures ($7.92K). Check Basel Medical Group Ltd Ordinary Shares tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Basel Medical Group Ltd Ordinary Shares Capital Reinvestment Ratio (2022–2024)
This chart tracks Basel Medical Group Ltd Ordinary Shares's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see BMGL cash flow conversion.
Annual Capital Reinvestment Ratio for Basel Medical Group Ltd Ordinary Shares (2022–2024)
Year-by-year Capital Reinvestment Ratio for Basel Medical Group Ltd Ordinary Shares from 2022 to 2024. See Basel Medical Group Ltd Ordinary Shares free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $2.51 Million | $7.92K | ▲ +33.2% |
| 2023 | 0.00x | $2.60 Million | $6.16K | ▼ -92.5% |
| 2022 | 0.03x | $2.79 Million | $88.50K | — |